Dimensional Fund Advisors’s Oncolytics Biotech ONCY Stock Holding History

Dimensional Fund Advisors’s Portfolio ONCY Stock Details ONCY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-33,485	Closed	-$73K	–	3443
2023 Q3	$73K	Hold	33,485	–	–	﹤0.01%	3350
2023 Q2	$87.1K	Hold	33,485	–	–	﹤0.01%	3343
2023 Q1	$40.2K	Hold	33,485	–	–	﹤0.01%	3402
2022 Q4	$55	Hold	33,485	–	–	﹤0.01%	3388
2022 Q3	$41K	Hold	33,485	–	–	﹤0.01%	3425
2022 Q2	$33K	Hold	33,485	–	–	﹤0.01%	3427
2022 Q1	$53K	Hold	33,485	–	–	﹤0.01%	3456
2021 Q4	$47K	Hold	33,485	–	–	﹤0.01%	3497
2021 Q3	$70K	Buy	+33,485	New	+$75.8K	﹤0.01%	3453

Other funds holding ONCY

AFM

Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

IAIM

International Assets Investment Management Orlando, Florida $1.44B AUM 21.92% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

ARC

Advisor Resource Council Dallas, Texas $309M AUM 22.32% 1-Year Est. Return

CIBC World Market Toronto, Ontario, Canada $61.3B AUM 39.33% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors's ONCY Position: Q4 2023 in Review

Dimensional Fund Advisors sold out of Oncolytics Biotech (ONCY) in Q4 2023, closing a stake of 33,485 shares — an estimated $73K sold.

Dimensional Fund Advisors first reported a position in ONCY in Q3 2021 and held it in 9 quarters. The position peaked at $87.1K in Q2 2023. 44 funds tracked by Wall St. Rank hold ONCY as of Q4 2023.

Dimensional Fund Advisors reported no remaining Oncolytics Biotech position as of Q4 2023 after selling out during the quarter.
Dimensional Fund Advisors sold 33,485 Oncolytics Biotech shares in Q4 2023, an estimated $73K.
Dimensional Fund Advisors first reported a position in Oncolytics Biotech in Q3 2021 and held it in 9 quarters.
Dimensional Fund Advisors's Oncolytics Biotech position peaked at $87.1K in Q2 2023.
44 funds tracked by Wall St. Rank held Oncolytics Biotech as of Q4 2023.

Based on Dimensional Fund Advisors's 13F filing for Q4 2023, filed 7 Feb 2024.